Rocket


Overview
Financials
News + Filings
Key Docs
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Gamida Cell Ltd. (GMDA) Create: Alert

All | News | Filings
Date FiledTypeDescription
09/27/2023 8-K Regulation FD Disclosure, Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "First Patient Receives Gamida Cell’ s Omisirge™"
08/14/2023 8-K Entry into a Material Definitive Agreement, Results of Operations and Financial Condition, Departure of Directors or Certain ...
Docs: "Gamida Cell Reports Second Quarter and First Half 2023 Financial Results and Provides Company Update"
05/19/2023 8-K Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Submission of Matters to a Vote of Security Holders...
Docs: "Amended and Restated Articles of Association of the Registrant, as currently in effect"
04/21/2023 8-K Quarterly results
04/17/2023 8-K Quarterly results
03/27/2023 8-K Results of Operations and Financial Condition, Cost Associated with Exit or Disposal Activities, Financial Statements and Exh...
Docs: "Gamida Cell Reports Full Year 2022 Financial Results and Provides Company Update"
03/20/2023 8-K Quarterly results
01/30/2023 8-K Other Events, Financial Statements and Exhibits  Interactive Data
01/19/2023 8-K Quarterly results
01/09/2023 8-K Quarterly results
12/12/2022 8-K Quarterly results
11/21/2022 8-K Quarterly results
11/14/2022 8-K Quarterly results
09/30/2022 8-K Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "GAMIDA CELL LTD. 12,905,000 Shares ORDINARY SHARES, NOMINAL VALUE NIS 0.01 PER SHARE UNDERWRITING AGREEMENT September 27, 2022",
"OPINION OF MEITAR | LAW OFFICES",
"Media Inquiries:"
09/27/2022 8-K Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "Media Inquiries:"
09/19/2022 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "Agreement”), dated as of September 18, 2022 is by and between GAMIDA CELL INC., a Delaware Corporation , and ABIGAIL JENKINS",
"Gamida Cell Appoints Abigail L. Jenkins as President and Chief Executive Officer, Bringing Broad Leadership Experience in Commercializing Innovative Therapies"
08/15/2022 8-K Quarterly results
08/10/2022 8-K Quarterly results
08/01/2022 8-K Regulation FD Disclosure, Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "Gamida Cell Announces FDA Acceptance of Biologics License Application for Omidubicel with Priority Review"
07/29/2022 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
06/10/2022 8-K Quarterly results
06/02/2022 8-K Regulation FD Disclosure, Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "Gamida Cell Completes Rolling Biologics License Application Submission to the FDA for Omidubicel"
05/10/2022 8-K Quarterly results
Docs: "Gamida Cell Reports First Quarter 2022 Financial Results and Provides Company Update"
04/26/2022 8-K Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "Gamida Cell Announces FDA Clearance of IND and Removal of Clinical Hold for NK Cell Therapy Candidate GDA-201"
03/15/2022 8-K Results of Operations and Financial Condition, Financial Statements and Exhibits  Interactive Data
Docs: "Gamida Cell Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Company Update"
02/09/2022 8-K Quarterly results
01/31/2022 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "Gamida Cell Announces Appointment of Anat Cohen-Dayag and Naama Halevi-Davidov to its Board of Directors"
01/31/2022 8-K Cost Associated with Exit or Disposal Activities, Other Events, Financial Statements and Exhibits  Interactiv...
Docs: "Gamida Cell Provides Key Program Updates and 2022 Financial Guidance"
01/19/2022 8-K Other Events, Financial Statements and Exhibits
Docs: "Gamida Cell Provides Update on Omidubicel BLA Submission"
01/03/2022 8-K Regulation FD Disclosure

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy